Creative Medical Technology Holdings Inc (CELZ)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Creative Medical Technology Holdings Inc (CELZ) is down 1.5% since the beginning of the year. At $2 per share, CELZ is trading 69.1% below its 52-week high of $6. Investors who bought $1,000 worth of CELZ shares 5 years ago would now be looking at an investment worth $11.

Creative Medical Technology Holdings Inc (CELZ) has returned -1.53% so far this year and -21.86% over the past 12 months. Over the last ten years, CELZ has returned -69.15% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Nov 6, 2015, CELZ's average daily return is +2.17%, while the average monthly return is +43.75%. At this rate, an investment would double in approximately 0.2 years.

Historically, 27% of months were positive and 73% were negative. The best month was Apr 2016 with a return of +4,445.5%, while the worst month was Nov 2017 at -77.8%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 10 months.

On a daily basis, CELZ closed higher 34% of trading days. The best single day was Apr 28, 2016 with a return of +4,445.5%, while the worst single day was May 18, 2016 at -80.0%.

Creative Medical Technology Holdings Inc has an annualized alpha of 25618.82%, beta of -1.06, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since November 06, 2015.

• This stock participated in 242.10% of S&P 500 Index downside but only -24.51% of its upside - more exposed to losses than it benefited from rallies.
• Beta of -1.06 may look defensive, but with R2 of 0.00 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

CELZ ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Creative Medical Technology Holdings Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Creative Medical Technology Holdings Inc was 100.00%, occurring on Feb 5, 2026. The portfolio has not yet recovered.

The current Creative Medical Technology Holdings Inc drawdown is 100.00%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Creative Medical Technology Holdings Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Creative Medical Technology Holdings Inc is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.